Project Grant R43AG071102

Award Date 9/30/21
Completion Date 8/31/23
Dollars Obligated $1.7M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Novato, CA 94949, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $349,333.00 to Rendever, Inc. to develop and test the feasibility of a new virtual reality (VR) platform tailored for dementia caregivers. The project, titled "VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support", aims to create a VR-based system that can alleviate feelings of loneliness and stress, and cultivate resilience and...
The National Institute on Aging (NIA) awarded a $1,010,368 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to Koronis Biomedical Technologies Corporation (KBT) to develop and validate an interactive gaming platform that facilitates cognitive interventions for individuals living with mild cognitive impairment (MCI), Alzheimer's disease (AD), and related dementias (ADRD). The proposed research seeks to build an in-home cognition training system that provides a modular...
This National Institute on Aging (NIA) Project Grant award (CFDA 93.866 - Aging Research) provides $864,674 to Lifebio Inc., a small disadvantaged woman-owned business, to develop a tablet-based platform called LifeBioTalk. The LifeBioTalk system uses a human-like avatar to provide engaging audiovisual content and simulated conversation for people with Alzheimer's disease and related dementias (ADRD). The goal is to reduce challenging behaviors and caregiver burden through this interactive...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the federal Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to improve long-term care (LTC) quality and safety for individuals living with dementia. With $449,999 in funding, the 3-year project starting September 2024 will implement and evaluate two decision support technology (DS tech) prototypes focused on fall prevention and staff burnout detection in LTC facilities. The...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Dartmouth-Hitchcock Clinic aims to modify and evaluate an existing online platform called iPATH*D. The goal is to connect caregivers of people living with Alzheimer's disease or related dementias who screen positive for depression to evidence-based mental health treatments. The $170,593 award will fund activities to optimize the platform's screening and referral pathway, as well as assess its...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Rochester provides $2,247,334 in funding to study the impact of telemedicine use among assisted living residents with Alzheimer's disease and related dementias (ADRD). The study aims to examine how assisted living facility-level resources, local market direct care workforce factors, and state-level regulations influence the use of telemedicine services by this population. The project...
This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
The National Institute on Aging awarded a $232,485 Project Grant (CFDA 93.866 - Aging Research) to the University of Alabama at Birmingham (UAB) to adapt and test the feasibility of an artificial intelligence (AI)-enabled web app based on Acceptance and Commitment Therapy (ACT) for family caregivers of people with dementia. The project aims to adapt the ACT-based web app, named WEACT, through collaboration with a community advisory board, and then evaluate the feasibility, acceptability, and...

ASSESSING A NOVEL VIRTUAL ENVIRONMENT THAT PRIMES INDIVIDUALS LIVING WITH AD/ADRD TO ACCOMPLISH ACTIVITIES OF DAILY LIVING. - ABSTRACT THE PREVALENCE OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD) IS GROWING IN AN INCREASINGLY AGING POPULATION. CARE CHALLENGES TO MAINTAIN HEALTH AND QUALITY LIFE FOR PERSONS LIVING WITH DEMENTIAS (PLWD) HAS ALSO CREATED A PARALLEL HEALTH PROBLEM FROM THE EFFECTS OF PERSISTENT CAREGIVER JOB STRESS, RESULTING IN STAFF TURNOVER EXPENSE AND CARE OPERATIONS RISK IN A SCARCE JOB POOL. IMPROVING THE RATE OF COMPLETION OF ACTIVITIES OF DAILY LIVING (ADL) HAS A KNOWN POSITIVE IMPACT ON THE QUALITY OF LIFE, HEALTH, AND HEALTHCARE COSTS YET CONSISTENTLY COMPLETING ADLS, AND WITHOUT STRESS, FOR PLWD AND THEIR CARERS REMAINS A CHALLENGE. WE HYPOTHESIZE THAT UNDERTAKING VIRTUAL ADL ACTIVITIES WILL POSITIVELY IMPACT ACTUAL ADL ACTIVITIES, RESULTING IN EASIER AND MORE EFFICIENT ADL COMPLETION AND THEREFORE DECREASE CAREGIVER STRESS, AND, WITH DIGNITY, IMPROVE THE HEALTH AND QUALITY OF LIFE FOR PLWD. MENTIA IS AN EARLY-STAGE DIGITAL HEALTH COMPANY THAT HAS DEVELOPED DEVAWORLD, A NOVEL TECHNOLOGY PLATFORM FOCUSED ON IMPROVING BEHAVIORAL HEALTH FOR PEOPLE IMPACTED BY ADRD. DEVAWORLD, AS AN ASSISTIVE SOFTWARE APPLICATION TECHNOLOGY, IS UNIQUE IN THAT IT CONSIDERS CARE AS A PARTNERSHIP, WITH THE CARE RECIPIENT BEING AN ACTIVE PARTICIPANT, EVEN THOUGH THEIR DEMENTIA MAY BE SEVERE. THE COST-EFFECTIVE PLATFORM CONSISTS OF A MEDIA-RICH 3D VIRTUAL HOME WITH INTERACTIVE ITEMS AND ACTIVITIES THAT CAN BE USED TO BUILD COMMUNICATION WITHIN THE CARE DYAD AND FOSTER A SENSE OF AGENCY AND IDENTITY. THE GOAL OF THE PROPOSED WORK IS TO DEMONSTRATE TOLERABILITY AND ACCEPTABILITY OF DEVAWORLD, AND ASSESS THE IMPACT OF VIRTUAL ADL ACTIVITY ON BOTH PARTNERS OF THE DYAD, PAYING SPECIAL ATTENTION TO HOW CONSISTENT PERFORMANCE OF ADLS INSIDE DEVAWORLD BY PLWD REDUCES CAREGIVER STRESS. IN THIS WORK, TWO SPECIFIC AIMS ARE PROPOSED: AIM 1: EXPAND DEVAWORLD TO INCLUDE ENVIRONMENTS AND ACTIVITIES MOST OFTEN CITED AS CHALLENGES IN REGARD TO ADLS. WE HYPOTHESIZE THAT PLAYERS CAN BE PREPARED TO PERFORM ADLS VIA VIRTUAL WORLD INTERACTIONS. THIS AIM ENTAILS THE DESIGN OF SETTINGS, ACTIVITIES, AND INTERACTIVE AVATAR ACTIONS WITHIN DEVAWORLD INTENDED TO PREPARE THE PLAYER IN SELECTED ADLS. AIM 2: DEMONSTRATE FEASIBILITY AND ACCEPTABILITY OF DEVAWORLD IN A FEASIBILITY STUDY. QUALITATIVE MEASUREMENTS USING ECOLOGICAL MOMENTARY ASSESSMENTS (EMAS) AND QUANTITATIVE MEASUREMENTS OF INDEPENDENCE THROUGH ACTIVITIES OF DAILY LIVING (ADL) SCALE ASSESSMENTS WILL BE ASSESSED WHILE 16 PLAYERS WITH ADRD UNDERTAKE VIRTUAL AND REAL-WORLD ADLS (AIM 1) (SINGLE GROUP STUDY). THE PRIMARY OUTCOME OF THIS AIM IS TOLERABILITY AND ACCEPTABILITY OF DEVAWORLD ASSESSED BY CAREGIVER SURVEYS AND EMAS. THE SECONDARY OUTCOME IS FEASIBILITY AND EFFICACY OF PREPARING ADLS USING DEVAWORLD ASSESSED BY AMMODE, VALIDATED CAREGIVER SURVEYS OF STRESSORS AND ADL SCALE ASSESSMENT SCORES.

Posted 9/16/21, 12:00 AM